Novo Nordisk A S NVO Cash Flow Statement (2012-2019)

NYSE NVO
$38.63 +0.48 (+1.26%)
At close: Oct 9, 2026 · 4:00 PM EDT
Reported Financials

Novo Nordisk A S Quarterly Cash Flow Statement

Periods 29 quarters
Latest Dec 2019

Novo Nordisk A S cash flow statement data for the quarter ended Dec 2019. This cash flow statement covers 29 quarters of results from Mar 2012 through Dec 2019, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Dec2019
Operating Activities
Net Income
1.29B1.15B26.48B1.49B1.23B1.25B34.86B1.40B1.51B1.47B37.92B1.45B1.47B1.54B1.31B1.77B1.65B1.40B1.29B48.55B
Other non-cash items
4.16B
Change in Working Capital
2.15B2.16B
Change in Other Operating AssetsOther Assets Change
77.06B91.80B97.54B
Other Working Capital Changes
-77.06B-91.80B-97.54B
Other Operating Activities
0.13B
Cash from Operations
1.49B2.19B31.69B0.62B1.78B1.80B1.49B1.10B2.18B2.28B1.61B1.73B1.50B2.02B0.99B1.62B2.54B1.80B1.10B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.12B0.21B3.44B0.10B0.10B0.09B0.09B0.11B0.11B0.10B0.13B0.11B0.14B0.12B0.12B0.12B0.26B
Investing Activities
Capital Expenditures
0.15B0.18B3.99B0.12B0.15B0.19B6.41B0.16B0.25B0.27B8.27B0.23B0.28B0.33B0.47B0.38B0.25B0.36B0.51B
Sales of Property, Plant and Equipment
0.00B
Change in Property, Plant and Equipment
-0.15B-0.18B-3.99B-0.12B-0.15B-0.19B-6.41B-0.16B-0.25B-0.27B-8.27B-0.23B-0.28B-0.33B-0.47B-0.38B-0.25B-0.36B-0.51B
Change in Intangibles
0.32B1.18B
Divestments
0.36B
Net of Acquisitions & Divestments
0.36B
Purchase of InvestmentsInvestments Purchased
0.02B3.53B
Sale and Maturity of InvestmentsInvestments Sold
2.23B
Other Investing ActivitiesOther investing
0.04B0.03B
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
40.29B46.97B45.27B
Net Shares Issued and Repurchased
14.67B17.20B45.27B
Net Equity Issued and Repurchased
14.67B17.20B45.27B
Dividend Payments
Dividends Paid - Common and Prefferd
11.87B12.90B
Misc.
Cash from Financing Activities
26.53B30.10B
Exchange Rate Effect
0.07B
Change in Cash
1.33B2.00B27.40B0.85B1.61B1.61B1.01B0.94B1.92B1.87B39.99B1.49B1.24B1.71B0.50B1.20B2.13B1.36B0.47B
Ending Cash Balance
13.68B15.85B18.46B20.22B
Free Cash Flow
1.34B2.02B27.70B0.51B1.63B1.62B-4.92B0.94B1.93B2.01B-6.66B1.50B1.21B1.69B0.52B1.24B2.29B1.44B0.59B
Net Cash Flow
1.49B2.19B58.23B0.62B1.78B1.80B31.59B1.10B2.18B2.28B1.61B1.73B1.50B2.02B0.99B1.62B2.54B1.80B1.10B
Interest Paid
0.08B0.06B
Additional items
Income Taxes PaidTaxes Paid
7.91B9.37B

Novo Nordisk A S Cash Flow Statement API

Pull Novo Nordisk A S's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY